… in the development of lung cancer among Asian never smoking women. The median age
of diagnosis in Asian patients with lung cancer is generally younger than Caucasian patients, …

… from East Asia, whereas non-Asians were large and … Asian and non-Asian patients from
both separated Asian trials/non-Asian trials and trials enrolling Asian and non-Asian patients. …

… of our lung cancer patients who were Chinese compared to … hospital and racial breakdown
of patients attending our hospital in … , lung cancer was still most common among the Chinese. …

… populations, particularly Asian and non-Asian patients, for … for lung cancer (JME) study and
The Cancer Genome Atlas (TCGA) to clarify differences in mutation profiles for lung cancer by …

… EGFR mutations in patients of different Asian ethnicities and … in Asian patients applies to
all subgroups of Asian patients. … Pan-Asia Study (IPASS) population, 3 with patients of female …

… The EGFR mutation and its correlation with response of gefitinib in previously treated
Chinese patients with advanced non-small-cell lung cancer. Ann Oncol 2005;16:1334-42 …

… This review discusses the use of gefitinib in Asian patients with advanced … Asian and
non-Asian patients. Reports of Phase II/III clinical experience with gefitinib 250 mg/day in Asia were …

… patients with non-small cell lung cancer presented with either locally advanced or metastatic
disease. Although it is possible that young lung cancer patients … young lung cancer patients …

… -line treatment of patients with EGFR mutation-positive advanced non-small-cell lung cancer
(… regimen widely used in Asia—for first-line treatment of Asian patients with EGFR mutation-…

… -cell lung cancer (NSCLC) following docetaxel and carboplatin, and to explore potential
differences in these end points between Caucasian and Asian patients. Patients and methods …